RNA Therapeutics Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
RNA Therapeutics Market is Segmented By Type of Modality (RNA Therapeutics, RNA Vaccines), By Type of Molecule (Replicating RNA (repRNA), Self amplifying RNA (saRNA), Self activating RNA (sacRNA), Self activating mRNA (samRNA), Transfer RNA (tRNA)). The report offers the value (in USD million) for the above-mentioned segments.
Competitive overview of RNA Therapeutics Market
The major players operating in the RNA Therapeutics Market include Alphavax, Arcturus Therapeutics, Atyr Pharma, Gritstone Bio, HDT Bio, Laronde Therapeutics, MiNA Therapeutics, Orna Therapeutics, Recode Therapeutics, Renegade Therapeutics, Replicate Bioscience, Shape Therapeutics, and VLP Therapeutics
RNA Therapeutics Market Leaders
- Alphavax
- Arcturus Therapeutics
- Atyr Pharma
- Gritstone Bio
- HDT Bio
*Disclaimer: Major players are listed in no particular order.
RNA Therapeutics Market - Competitive Rivalry, 2023
RNA Therapeutics Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights